These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 18439942)

  • 21. Prognostic value of p53, Ki-67, microstaging and microvessel density in pT1G3 bladder tumors: creation of risk groups for progression.
    Queipo-Zaragoza JA; Ruiz-Cerda JL; Vera-Donoso CD; Vera-Sempere F; Budia-Alba A; Jimenez-Cruz JF
    Scand J Urol Nephrol; 2007; 41(4):283-9. PubMed ID: 17763218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic relevance of intracytoplasmic cytokeratin pattern, hormone expression profile, and cell proliferation in pituitary adenomas of akromegalic patients.
    Mazal PR; Czech T; Sedivy R; Aichholzer M; Wanschitz J; Klupp N; Budka H
    Clin Neuropathol; 2001; 20(4):163-71. PubMed ID: 11495005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of immunohistochemical expression of p53 and the proliferation marker Ki-67 antigen in skull base chordomas: relationships between their expression and prognosis.
    Sakai K; Hongo K; Tanaka Y; Nakayama J
    Brain Tumor Pathol; 2007; 24(2):57-62. PubMed ID: 18095132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of Ki-67 labeling index in pituitary adenomas using MIB-1 monoclonal antibody.
    Lath R; Chacko G; Chandy MJ
    Neurol India; 2001 Jun; 49(2):144-7. PubMed ID: 11447433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Typical and atypical pituitary adenomas: a single-center analysis of outcome and prognosis.
    Chiloiro S; Doglietto F; Trapasso B; Iacovazzo D; Giampietro A; Di Nardo F; de Waure C; Lauriola L; Mangiola A; Anile C; Maira G; De Marinis L; Bianchi A
    Neuroendocrinology; 2015; 101(2):143-50. PubMed ID: 25633744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive markers of pituitary adenoma behavior.
    Kontogeorgos G
    Neuroendocrinology; 2006; 83(3-4):179-88. PubMed ID: 17047381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
    Suthipintawong C; Wejaranayang C; Vipupinyo C
    J Med Assoc Thai; 2008 Dec; 91(12):1779-84. PubMed ID: 19133508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical treatment of giant pituitary adenomas: strategies and results in a series of 95 consecutive patients.
    Mortini P; Barzaghi R; Losa M; Boari N; Giovanelli M
    Neurosurgery; 2007 Jun; 60(6):993-1002; discussion 1003-4. PubMed ID: 17538372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proliferative activity and genetic changes in adrenal cortical tumors examined by flow cytometry, fluorescence in situ hybridization and immunohistochemistry.
    Takehara K; Sakai H; Shono T; Irie J; Kanetake H
    Int J Urol; 2005 Feb; 12(2):121-7. PubMed ID: 15733104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ki-67 in pituitary neoplasms: a review--part I.
    Salehi F; Agur A; Scheithauer BW; Kovacs K; Lloyd RV; Cusimano M
    Neurosurgery; 2009 Sep; 65(3):429-37; discussion 437. PubMed ID: 19687686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ki-67 labeling index and expression of p53 are non-predictive for invasiveness and tumor size in functional and nonfunctional pituitary adenomas.
    Grimm F; Maurus R; Beschorner R; Naros G; Stanojevic M; Gugel I; Giese S; Bier G; Bender B; Honegger J
    Acta Neurochir (Wien); 2019 Jun; 161(6):1149-1156. PubMed ID: 31037500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathologic correlates of giant pituitary adenomas.
    Chacko G; Chacko AG; Lombardero M; Mani S; Seshadri MS; Kovacs K; Scheithauer BW
    J Clin Neurosci; 2009 May; 16(5):660-5. PubMed ID: 19285407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up.
    Trouillas J; Roy P; Sturm N; Dantony E; Cortet-Rudelli C; Viennet G; Bonneville JF; Assaker R; Auger C; Brue T; Cornelius A; Dufour H; Jouanneau E; François P; Galland F; Mougel F; Chapuis F; Villeneuve L; Maurage CA; Figarella-Branger D; Raverot G; ; Barlier A; Bernier M; Bonnet F; Borson-Chazot F; Brassier G; Caulet-Maugendre S; Chabre O; Chanson P; Cottier JF; Delemer B; Delgrange E; Di Tommaso L; Eimer S; Gaillard S; Jan M; Girard JJ; Lapras V; Loiseau H; Passagia JG; Patey M; Penfornis A; Poirier JY; Perrin G; Tabarin A
    Acta Neuropathol; 2013 Jul; 126(1):123-35. PubMed ID: 23400299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study of the MIB-1 labeling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents.
    Bowers DC; Gargan L; Kapur P; Reisch JS; Mulne AF; Shapiro KN; Elterman RD; Winick NJ; Margraf LR
    J Clin Oncol; 2003 Aug; 21(15):2968-73. PubMed ID: 12885817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pituitary macroadenomas (>3 cm) in young adulthood: Pathologic and proliferative characteristics.
    Öngürü Ö; Düz B; Şimşek H; Günal A; Gönül E
    Neurol Neurochir Pol; 2015; 49(4):212-6. PubMed ID: 26188936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated p21 expression is associated with poor prognosis of rectal stromal tumors after resection.
    Hu TH; Tai MH; Chuah SK; Chen HH; Lin JW; Huang HY; Chou YP; Yi LN; Kuo CM; Changchien CS
    J Surg Oncol; 2008 Aug; 98(2):117-23. PubMed ID: 18521824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relevance of Ki-67 and prognostic factors for recurrence/progression of gonadotropic adenomas after first surgery.
    Dubois S; Guyétant S; Menei P; Rodien P; Illouz F; Vielle B; Rohmer V
    Eur J Endocrinol; 2007 Aug; 157(2):141-7. PubMed ID: 17656591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Characterization and prognostic value of colorectal adenomas with molecular genetic markers].
    Di Stefano A; Fisichella P; Catanuto G; Di Blasi M; La Greca G; Grasso G; Russello D
    Minerva Chir; 2000 Mar; 55(3):99-104. PubMed ID: 10832292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Non-functioning pituitary adenomas: clinical features and immunohistochemistry].
    Ferreira JE; de Mello PA; de Magalhães AV; Botelho CH; Naves LA; Nosé V; Schmitt F
    Arq Neuropsiquiatr; 2005 Dec; 63(4):1070-8. PubMed ID: 16400431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between SPARC (Osteonectin) expression with immunophenotypical and invasion characteristics of pituitary adenomas.
    Onoz M; Basaran R; Gucluer B; Isik N; Kaner T; Sav A; Elmaci I
    APMIS; 2015 Mar; 123(3):199-204. PubMed ID: 25556322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.